Abstract
Catatonia is a syndrome of specific motor abnormalities closely associated with disorders in mood, affect, thought and cognition. The principal signs of the disorder are mutism, immobility, negativism, posturing, stereotypy and echo phenomena. Catatonia is commonly seen in various psychiatric disorders, neurological disorders and certain medical conditions. It has also been reported in individuals with substance withdrawal. But we are presenting the case of a patient with cannabis dependence, who presented with symptoms of catatonia preceded by an increase in the amount of cannabis intake and resolution of the catatonia when he abstained from the substance. Literature review did not show any case revealing association between cannabis to catatonia.
Similar content being viewed by others
References
Abrams, R., & Taylor, M. A. (1976). Catatonia: a prospective clinical study. Archives of General Psychiatry, 33(5), 579–581.
Coupar, I. M., & Taylor, D. A. (1982). Alteration in the levels of endogenous hypothalamic prostaglandins induced by tetrahydrocannabinol in the rat. British Journal of Pharmacology, 76, 115–119.
Fairbairn, J. W., & Pickens, J. T. (1979). The oral activity of tetrahydrocannabinol and its dependence on prostaglandin E2. British Journal of Pharmacology, 67, 379–385.
Fairbairn, J. W., & Pickens, J. T. (1980). The effect of conditions influencing endogenous prostaglandins on the activity of tetrahydrocannabinol in mice. British Journal of Pharmacology, 69, 491–493.
Gelenberg, A. J. (1976). The catatonic syndrome. Lancet, 1, 1339–1341.
Kahlbaum, K. L. (1874). Die Katatonie oder das Spannungsirresein. August Hirschwald.
Kraepelin, E. (1919). Dementia praecox and paraphrenia (trans: Barclay, R.M.). Edinburgh: E&S Livingstone.
Peralta, V., Cuesta, M. J., et al. (1997). The kahlbaum syndrome: a study of its clinical validity, nosological status, and relationship with schizophrenia and mood disorder. Comprehensive Psychiatry, 38, 61–67.